Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • zeam
    Member
    • Oct 2010
    • 43

    #1

    Cuffdiff:bug or misunderstanding

    Hi there,
    Recently, I'm using tophat and cufflinks to processing RNA -seq data.When I checked the cuffdiff results, I saw that if PRKM one of the sample was 0 then, then value of significant would be no.Take one gene for example,the gene below are significantly expressed in the two samples , but the p-value and the q-value are both not significant.Why was that happened? This is confusing me. My goal was to find differencially expressed genes , but how to choose a standard ?
    ###############################################
    XLOC_000278 XLOC_000278 GRMZM5G842168 chr0:3478602-3478782 q2 q3 OK 0 942.574 1.79769e+308 1.79769e+308 0.129087 0.611177 no
    ###############################################
    XLOC_000926 XLOC_000926 GRMZM2G046086 chr1:14288358-14288941 q2 q3 OK 0 34.8376 1.79769e+308 1.79769e+308 0.108366 0.595925 no
    ###############################################
    Thanks,
    Xie
    Last edited by zeam; 11-02-2011, 10:43 PM. Reason: Add more infor

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...